Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Zeribe C. Nwosu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1641-2045; OpenAlex author ID A5049268318; NIH RePORTER profile ID 16234805. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 0)
Trials
0
Grants
2
Labs led
1
Collaborators
57
Papers, trials and grants by year

2021: 5 papers · 2022: 3 papers · 2023: 2 papers, 1 grant · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper, 1 grant

Papers 13

  1. Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-25-1300↗
  2. Multidimensional analyses identify genes of high priority for pancreatic cancer research. Co-author DOI 10.1172/jci.insight.174264↗
  3. KRT17high/CXCL8+ Tumor Cells Display Both Classical and Basal Features and Regulate Myeloid Infiltration in the Pancreatic Cancer Microenvironment. Co-author DOI 10.1158/1078-0432.ccr-23-1421↗
  4. Uridine-derived ribose fuels glucose-restricted pancreatic cancer. Co-author DOI 10.1038/s41586-023-06073-w↗
  5. Arginase 1 is a key driver of immune suppression in pancreatic cancer. First author DOI 10.7554/elife.80721↗
  6. GOT2: An Unexpected Mediator of Immunosuppression in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-22-0845↗
  7. Combinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer. Co-author DOI 10.1371/journal.pgen.1010315↗
  8. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context. Co-author DOI 10.7554/elife.73245↗
  9. GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis. Co-author DOI 10.1038/s41467-021-24859-2↗
  10. Nutrient profiling reveals extracellular uridine as a fuel for pancreatic cancer through uridine phosphorylase 1 First author DOI 10.1101/2021.06.07.447448↗
  11. Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB-Mediated Production of CXCL1. Co-author DOI 10.1158/0008-5472.can-20-3929↗
  12. Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-20-3715↗
  13. Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages. Co-author DOI 10.26508/lsa.202000935↗

Grants 2

  1. Disrupting glutathione dependency in pancreatic cancer R00CA267176↗
  2. Disrupting glutathione dependency in pancreatic cancer K99CA267176↗

Closest collaborators

The 25 strongest of 57 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marina Pasca di Magliano · 13 shared papers, 2021–2026 · strength 1.83
  2. Costas Andreas Lyssiotis · 10 shared papers, 2021–2026 · strength 1.25
  3. Eileen S. Carpenter · 9 shared papers, 2021–2026 · strength 1.07
  4. Rosa Elena Menjivar · 7 shared papers, 2021–2026 · strength 1.00
  5. Nina G. Steele · 7 shared papers, 2021–2025 · strength 0.84
  6. Filip Bednar · 6 shared papers, 2021–2026 · strength 0.77
  7. Howard C. Crawford · 7 shared papers, 2021–2023 · strength 0.74
  8. Samantha B. Kemp · 6 shared papers, 2021–2025 · strength 0.72
  9. Katelyn L. Donahue · 5 shared papers, 2021–2026 · strength 0.67
  10. Yaqing Zhang · 6 shared papers, 2021–2023 · strength 0.65
  11. Christopher J. Halbrook · 6 shared papers, 2021–2023 · strength 0.65
  12. Timothy L. Frankel · 4 shared papers, 2021–2026 · strength 0.51
  13. Padma Kadiyala · 3 shared papers, 2023–2026 · strength 0.47
  14. Li Zhang · 3 shared papers, 2021–2023 · strength 0.34
  15. Ahmed M. Elhossiny · 2 shared papers, 2024–2026 · strength 0.33
  16. Wenting Du · 2 shared papers, 2023–2024 · strength 0.27
  17. Daniel James Salas-Escabillas · 2 shared papers, 2022–2023 · strength 0.26
  18. Jiaqi Shi · 2 shared papers, 2023–2024 · strength 0.26
  19. Matthew H. Ward · 2 shared papers, 2021–2023 · strength 0.24
  20. Anguraj Sadanandam · 2 shared papers, 2021–2023 · strength 0.24
  21. Valerie Gunchick · 2 shared papers, 2021–2024 · strength 0.23
  22. Vaibhav Sahai · 2 shared papers, 2021–2024 · strength 0.23
  23. Kenneth P. Olive · 2 shared papers, 2021–2022 · strength 0.21
  24. Benjamin Allen · 2 shared papers, 2021–2022 · strength 0.21
  25. Heather Marie Giza · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.